FBTCX
Price
$21.39
Change
-$0.04 (-0.19%)
Updated
Feb 21 closing price
Net Assets
1.54B
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

FBTCX vs JNGLX

Header iconFBTCX vs JNGLX Comparison
Open Charts FBTCX vs JNGLXBanner chart's image
Fidelity Advisor Biotechnology C
Price$21.39
Change-$0.04 (-0.19%)
VolumeN/A
Net Assets1.54B
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
FBTCX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTCX vs. JNGLX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTCX is a Buy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. FBTCX (1.54B). JNGLX pays higher dividends than FBTCX: JNGLX (0.12) vs FBTCX (0.00). FBTCX was incepted earlier than JNGLX: FBTCX (24 years) vs JNGLX (26 years). FBTCX is a more actively managed with annual turnover of: 78.00 vs. JNGLX (34.00). FBTCX has a lower initial minimum investment than JNGLX: FBTCX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -3.67 vs. FBTCX (-5.84). JNGLX return over 5 years is better than : 17.54 vs. FBTCX (-8.98).
FBTCXJNGLXFBTCX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years26 years-
Gain YTD1.5195.42128%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.54B5B31%
Annual Yield % from dividends0.000.12-
Returns for 1 year-5.84-3.67159%
Returns for 3 years19.4515.97122%
Returns for 5 years-8.9817.54-51%
Returns for 10 years-9.1329.25-31%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P